Key Market Indicators
Sales of hypnotic and sedative medicines in New Zealand are projected to reach $4.56 million by 2026. In 2021, these sales amounted to $3.63 million, increasing at an average rate of 4% year-on-year since 1998. Last year, New Zealand ranked 21st in this market, with Luxembourg leading the way at $3.63 million. Germany, Sweden and Belgium placed second, third, and fourth respectively.
